Exact Sciences Corp
(NAS:EXAS)
$
54.33
-0.39 (-0.71%)
Market Cap: 10.06 Bil
Enterprise Value: 11.87 Bil
PE Ratio: 0
PB Ratio: 3.13
GF Score: 80/100 Exact Sciences Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 13, 2020 / 01:00PM GMT
Release Date Price:
$84.59
(+1.49%)
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research
Good morning, everyone. This is Derik De Bruin, the Bank of America Life Sciences and Diagnostic Tools Analyst. Welcome to our Virtual Vegas Health Care Conference. We appreciate everyone being here today. Our next speaker today is -- presentation today is Exact Sciences. Here, we have Kevin Conroy for the company, CEO of the company, here with us to sort of update us on what's going on at Exact and the exciting world of colon cancer screening and now COVID testing. Kevin, welcome.
Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO
Thank you, Derik. Great to be here.
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research
Remember everybody, you can chat me questions. If you're dialed into Veracast line, please feel happy to do it.
Questions & Answers
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot